Influence of the selective serotonin re‐uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study th...

Full description

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 17; no. 4; pp. 603 - 608
Main Authors Tack, J., Broekaert, D., Coulie, B., Fischler, B., Janssens, J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 15.02.2003
Blackwell
Subjects
Online AccessGet full text
ISSN0269-2813
1365-2036
DOI10.1046/j.1365-2036.2003.01469.x

Cover

Abstract Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Methods : Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Results : Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL, P < 0.05). Conclusions : Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation.
AbstractList Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Methods : Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Results : Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL, P  < 0.05). Conclusions : Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation.
Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Methods : Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Results : Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL, P < 0.05). Conclusions : Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation.
The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine.BACKGROUNDThe role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine.To study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.AIMTo study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.METHODSSixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.Pre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05).RESULTSPre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05).Pre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation.CONCLUSIONSPre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation.
The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine. To study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Pre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05). Pre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation.
Author Coulie, B.
Fischler, B.
Tack, J.
Janssens, J.
Broekaert, D.
Author_xml – sequence: 1
  givenname: J.
  surname: Tack
  fullname: Tack, J.
– sequence: 2
  givenname: D.
  surname: Broekaert
  fullname: Broekaert, D.
– sequence: 3
  givenname: B.
  surname: Coulie
  fullname: Coulie, B.
– sequence: 4
  givenname: B.
  surname: Fischler
  fullname: Fischler, B.
– sequence: 5
  givenname: J.
  surname: Janssens
  fullname: Janssens, J.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14643943$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12622770$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1uFDEQhS0URCaBKyBvYJVu3LbH7l6AFEX8RIoEi7C2bKfMeOixB9sdJjuOwBk5CW5mCBIbWFVJ9b1XLr8TdBRiAIRwR9qOcPFi3XZMLBtKmGgpIawlHRdDu3uAFveDI7QgVAwN7Tt2jE5yXhNChCT0ETruqKBUSrJA6TK4cYJgAUeHywpwhhFs8bdzl2KJwQec4Me379O26M-AfVh540tMZ3irU9xB8QHOcAz4k84leVt1IcfkN1WcsJtCdavTarOaNjrkx-ih02OGJ4d6ij6-eX198a65ev_28uL8qrF8IEPTkYEbcwNCUAnLngmmeyMN0xq0MyCX0gCtdxgriXWDq-CSaGNBACVaSHaKnu99tyl-mSAXtfHZwjjqAHHKSjLS857zCj49gJPZwI3a1rfrdKd-_1IFnh0Ana0eXdLB-vyH44KzgbPKvdpzNsWcEzhlfdHz9SVpP6qOqDk-tVZzSmpOSc3xqV_xqV016P8yuN_xb-nLvfSrH-Huv3Xq_MP13LGf9ni05Q
CitedBy_id crossref_primary_10_1111_j_1365_2982_2007_00966_x
crossref_primary_10_1016_S0399_8320_06_73195_5
crossref_primary_10_1371_journal_pone_0157798
crossref_primary_10_1053_j_gastro_2017_11_279
crossref_primary_10_1038_ajg_2011_179
crossref_primary_10_1152_ajpgi_00044_2011
crossref_primary_10_1111_nmo_13146
crossref_primary_10_1177_1756283X11409279
crossref_primary_10_1038_nrgastro_2013_11
crossref_primary_10_1097_00132980_200502000_00016
crossref_primary_10_1517_14728214_2011_558502
crossref_primary_10_3390_gidisord6010016
crossref_primary_10_3748_wjg_15_6052
crossref_primary_10_1016_S2468_1253_18_30003_7
crossref_primary_10_1111_j_1365_2982_2006_00863_x
crossref_primary_10_3748_wjg_15_25
crossref_primary_10_1016_j_dld_2005_04_001
crossref_primary_10_1097_MD_0000000000017501
crossref_primary_10_1111_nmo_12210
crossref_primary_10_1177_26345161231160723
crossref_primary_10_1517_14656566_2010_501794
crossref_primary_10_1007_s11938_004_0012_6
crossref_primary_10_1111_j_1365_2036_2010_04522_x
crossref_primary_10_1111_j_1365_2982_2010_01613_x
crossref_primary_10_1111_j_1365_2982_2010_01655_x
crossref_primary_10_3389_fpsyt_2020_00172
crossref_primary_10_1016_j_gtc_2010_08_005
crossref_primary_10_1111_j_1365_2036_2006_02772_x
crossref_primary_10_1046_j_1365_2036_2003_01775_x
crossref_primary_10_1111_j_1365_2036_2009_04121_x
crossref_primary_10_1152_ajpgi_00020_2010
crossref_primary_10_6064_2012_424802
crossref_primary_10_1155_2015_168252
crossref_primary_10_1007_s00535_006_1966_z
crossref_primary_10_1111_j_1365_2036_2008_03677_x
crossref_primary_10_1517_14656566_2013_809063
crossref_primary_10_1053_j_gastro_2006_11_002
crossref_primary_10_1111_j_1365_2982_2006_00891_x
crossref_primary_10_1152_ajpgi_90525_2008
crossref_primary_10_1016_j_gastrohep_2012_05_002
crossref_primary_10_1111_j_1365_2036_2006_03005_x
crossref_primary_10_1111_j_1365_2982_2011_01671_x
crossref_primary_10_1177_1756283X10362639
crossref_primary_10_1097_00001574_200411000_00007
crossref_primary_10_1111_j_1365_2982_2006_00876_x
crossref_primary_10_1038_oby_2006_154
crossref_primary_10_1111_j_1365_2036_2005_02472_x
crossref_primary_10_1016_j_dld_2003_09_012
crossref_primary_10_1007_s11938_007_0069_0
crossref_primary_10_1111_jgh_13168
crossref_primary_10_1152_ajpgi_00252_2009
crossref_primary_10_1016_j_gtc_2014_11_003
crossref_primary_10_1016_j_aprim_2012_05_003
crossref_primary_10_1136_gutjnl_2015_310721
crossref_primary_10_1152_ajpgi_00046_2009
crossref_primary_10_1007_s40265_020_01362_4
crossref_primary_10_1111_j_1365_2036_2006_02951_x
crossref_primary_10_1111_j_1365_2036_2006_02930_x
crossref_primary_10_1053_j_gastro_2015_04_020
crossref_primary_10_1080_14656566_2019_1707805
crossref_primary_10_1007_s11894_008_0070_3
crossref_primary_10_1016_j_bpg_2004_04_003
crossref_primary_10_1371_journal_pone_0138927
crossref_primary_10_4062_biomolther_2012_096
crossref_primary_10_1111_j_1365_2982_2007_01068_x
crossref_primary_10_1007_s11894_005_0021_1
crossref_primary_10_1053_j_gastro_2004_05_030
crossref_primary_10_1097_01_mcg_0000156109_97999_d1
crossref_primary_10_1111_nmo_13491
crossref_primary_10_1002_14651858_CD008321
crossref_primary_10_3748_wjg_v12_i17_2694
crossref_primary_10_3748_wjg_v12_i9_1329
crossref_primary_10_1038_ajg_2017_52
crossref_primary_10_1111_j_1365_2982_2004_00613_x
crossref_primary_10_5812_jamm_30057
crossref_primary_10_1159_000357854
crossref_primary_10_1016_j_coph_2007_09_012
crossref_primary_10_2478_sjecr_2020_0031
crossref_primary_10_1007_s11938_005_0026_8
crossref_primary_10_1016_S1542_3565_05_00531_8
crossref_primary_10_1111_j_1365_2036_2005_02392_x
crossref_primary_10_1111_j_1365_2036_2005_02471_x
crossref_primary_10_1586_17474124_2_3_411
crossref_primary_10_1517_14740338_5_2_313
crossref_primary_10_1371_journal_pone_0169113
crossref_primary_10_1007_s11938_007_0068_1
crossref_primary_10_1016_j_amjms_2020_04_018
Cites_doi 10.1136/gut.51.2.212
10.1053/gast.2002.33663
10.1113/jphysiol.1967.sp008334
10.1046/j.1365-2036.1998.00366.x
10.1097/00004714-199812000-00005
10.1016/0165-1838(93)90330-W
10.1016/0016-5085(95)90057-8
10.1136/gut.51.2.219
10.1136/gut.42.6.823
10.1016/S0016-5085(98)70012-5
10.1046/j.1365-2982.2002.00344.x
10.1136/gut.35.3.327
10.1007/BF02213124
10.1136/gut.35.4.496
10.1113/jphysiol.1981.sp013599
10.1038/351477a0
10.1111/j.1476-5381.1979.tb16089.x
10.1136/gut.46.4.468
ContentType Journal Article
Copyright 2003 INIST-CNRS
Copyright_xml – notice: 2003 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1046/j.1365-2036.2003.01469.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2036
EndPage 608
ExternalDocumentID 12622770
14643943
10_1046_j_1365_2036_2003_01469_x
APT1469
Genre article
Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YOC
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4909-1094bbde6627e58363a8b7b3aaeafbe757be2262bc70cf9fe6650abce6e20a673
IEDL.DBID DR2
ISSN 0269-2813
IngestDate Fri Jul 11 02:46:02 EDT 2025
Wed Feb 19 02:34:47 EST 2025
Mon Jul 21 09:14:01 EDT 2025
Thu Apr 24 22:58:23 EDT 2025
Tue Jul 01 00:27:24 EDT 2025
Wed Jan 22 16:26:52 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Stomach
Paroxetine
Healthy subject
Serotonin
Digestive system
Postprandial
Smooth muscle
Reuptake inhibitor
Sensitivity
Piperidine derivatives
Gastric fundus
Muscular tonus
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4909-1094bbde6627e58363a8b7b3aaeafbe757be2262bc70cf9fe6650abce6e20a673
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 12622770
PQID 73084844
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_73084844
pubmed_primary_12622770
pascalfrancis_primary_14643943
crossref_citationtrail_10_1046_j_1365_2036_2003_01469_x
crossref_primary_10_1046_j_1365_2036_2003_01469_x
wiley_primary_10_1046_j_1365_2036_2003_01469_x_APT1469
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-02-15
PublicationDateYYYYMMDD 2003-02-15
PublicationDate_xml – month: 02
  year: 2003
  text: 2003-02-15
  day: 15
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle Alimentary pharmacology & therapeutics
PublicationTitleAlternate Aliment Pharmacol Ther
PublicationYear 2003
Publisher Blackwell Science Ltd
Blackwell
Publisher_xml – name: Blackwell Science Ltd
– name: Blackwell
References 1987; 252
1998; 18
2002; 14
1981; 311
1991; 35
1967; 192
2002; 51
2000; 46
1993; 43
1997; 110
1986; 251
2002; 122
1995; 108
1996; 41
1994; 35
1998; 115
1979; 66
1998; 42
1998; 12
1993; 384
e_1_2_13_12_2
e_1_2_13_13_2
e_1_2_13_23_2
e_1_2_13_15_2
e_1_2_13_20_2
e_1_2_13_10_2
e_1_2_13_11_2
e_1_2_13_21_2
e_1_2_13_8_2
e_1_2_13_7_2
Azpiroz F (e_1_2_13_4_2) 1986; 251
e_1_2_13_6_2
De Ponti F (e_1_2_13_3_2) 1987; 252
e_1_2_13_5_2
Meulemans AL (e_1_2_13_14_2) 1993; 384
e_1_2_13_9_2
e_1_2_13_2_2
e_1_2_13_16_2
e_1_2_13_17_2
e_1_2_13_18_2
e_1_2_13_19_2
Coulie B (e_1_2_13_22_2) 1997; 110
References_xml – volume: 46
  start-page: 468
  year: 2000
  end-page: 73
  article-title: Effect of sumatriptan on gastric fundus tone and on the perception of gastric distension in man
  publication-title: Gut
– volume: 35
  start-page: 496
  year: 1994
  end-page: 500
  article-title: 5‐Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5‐hydroxytryptamine reuptake
  publication-title: Gut
– volume: 43
  start-page: 241
  year: 1993
  end-page: 6
  article-title: Role of nitric oxide and vasoactive intestinal polypeptide in vagally mediated relaxation of the gastric corpus in the anaesthetized ferret
  publication-title: J Autonomic Nervous System
– volume: 42
  start-page: 823
  year: 1998
  end-page: 9
  article-title: Responses to gastric distension in functional dyspepsia
  publication-title: Gut
– volume: 51
  start-page: 212
  year: 2002
  end-page: 8
  article-title: Role of nitric oxide in gastric motor and sensory functions in healthy subjects
  publication-title: Gut
– volume: 192
  start-page: 823
  year: 1967
  end-page: 46
  article-title: 5‐Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach
  publication-title: J Physiol
– volume: 110
  start-page: A767
  year: 1997
  article-title: Influence of buspirone‐induced fundus relaxation on the perception of gastric distension in man
  publication-title: Gastroenterology
– volume: 12
  start-page: 761
  year: 1998
  end-page: 6
  article-title: Influence of cisapride on gastric tone and on the perception of gastric distension
  publication-title: Aliment Pharmacol Ther
– volume: 252
  start-page: G595
  year: 1987
  end-page: 601
  article-title: Reflex gastric relaxation in response to distension of the duodenum
  publication-title: Am J Physiol
– volume: 122
  start-page: 1738
  year: 2002
  end-page: 47
  article-title: Clinical and pathophysiological characteristics of acute‐onset functional dyspepsia
  publication-title: Gastroenterology
– volume: 18
  start-page: 447
  issue: 6
  year: 1998
  end-page: 54
  article-title: Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review
  publication-title: J Clin Psychopharmacol
– volume: 41
  start-page: 689
  year: 1996
  end-page: 96
  article-title: Impaired accommodation of proximal stomach to a meal in functional dyspepsia
  publication-title: Dig Dis Sci
– volume: 384
  start-page: 424
  year: 1993
  end-page: 30
  article-title: The role of nitric oxide (NO) in 5‐HT induced relaxations of the guinea‐pig stomach
  publication-title: Naunyn-Schmiedeberg's Arch Pharmacol
– volume: 66
  start-page: 7
  year: 1979
  end-page: 9
  article-title: Uptake and release of 5‐hydroxytryptamine by enteric 5‐hydroxytryptaminergic neurones: effects of fluoxetine and chlorimipramine
  publication-title: Br J Pharmacol
– volume: 35
  start-page: 477
  year: 1991
  end-page: 9
  article-title: Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid
  publication-title: Nature
– volume: 35
  start-page: 327
  year: 1994
  end-page: 32
  article-title: Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients
  publication-title: Gut
– volume: 14
  start-page: 395
  year: 2002
  end-page: 402
  article-title: Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans
  publication-title: Neurogastroenterol Motil
– volume: 51
  start-page: 219
  year: 2002
  end-page: 24
  article-title: Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans
  publication-title: Gut
– volume: 115
  start-page: 1346
  year: 1998
  end-page: 52
  article-title: Role of impaired gastric accommodation to a meal in functional dyspepsia
  publication-title: Gastroenterology
– volume: 311
  start-page: 475
  year: 1981
  end-page: 88
  article-title: The electrical basis for contraction and relaxation in canine fundal smooth muscle
  publication-title: J Physiol
– volume: 251
  start-page: G727
  year: 1986
  end-page: 35
  article-title: Vagally mediated gastric relaxation induced by intestinal nutrients in the dog
  publication-title: Am J Physiol
– volume: 108
  start-page: 330
  year: 1995
  end-page: 6
  article-title: Gastric tone determines the sensitivity of the stomach to distension
  publication-title: Gastroenterology
– ident: e_1_2_13_8_2
  doi: 10.1136/gut.51.2.212
– volume: 384
  start-page: 424
  year: 1993
  ident: e_1_2_13_14_2
  article-title: The role of nitric oxide (NO) in 5‐HT induced relaxations of the guinea‐pig stomach
  publication-title: Naunyn-Schmiedeberg's Arch Pharmacol
– ident: e_1_2_13_16_2
  doi: 10.1053/gast.2002.33663
– ident: e_1_2_13_13_2
  doi: 10.1113/jphysiol.1967.sp008334
– ident: e_1_2_13_21_2
  doi: 10.1046/j.1365-2036.1998.00366.x
– ident: e_1_2_13_18_2
  doi: 10.1097/00004714-199812000-00005
– volume: 251
  start-page: G727
  year: 1986
  ident: e_1_2_13_4_2
  article-title: Vagally mediated gastric relaxation induced by intestinal nutrients in the dog
  publication-title: Am J Physiol
– volume: 252
  start-page: G595
  year: 1987
  ident: e_1_2_13_3_2
  article-title: Reflex gastric relaxation in response to distension of the duodenum
  publication-title: Am J Physiol
– ident: e_1_2_13_6_2
  doi: 10.1016/0165-1838(93)90330-W
– ident: e_1_2_13_20_2
  doi: 10.1016/0016-5085(95)90057-8
– ident: e_1_2_13_7_2
  doi: 10.1136/gut.51.2.219
– volume: 110
  start-page: A767
  year: 1997
  ident: e_1_2_13_22_2
  article-title: Influence of buspirone‐induced fundus relaxation on the perception of gastric distension in man
  publication-title: Gastroenterology
– ident: e_1_2_13_12_2
  doi: 10.1136/gut.42.6.823
– ident: e_1_2_13_11_2
  doi: 10.1016/S0016-5085(98)70012-5
– ident: e_1_2_13_23_2
  doi: 10.1046/j.1365-2982.2002.00344.x
– ident: e_1_2_13_9_2
  doi: 10.1136/gut.35.3.327
– ident: e_1_2_13_10_2
  doi: 10.1007/BF02213124
– ident: e_1_2_13_19_2
  doi: 10.1136/gut.35.4.496
– ident: e_1_2_13_2_2
  doi: 10.1113/jphysiol.1981.sp013599
– ident: e_1_2_13_5_2
  doi: 10.1038/351477a0
– ident: e_1_2_13_17_2
  doi: 10.1111/j.1476-5381.1979.tb16089.x
– ident: e_1_2_13_15_2
  doi: 10.1136/gut.46.4.468
SSID ssj0006702
Score 2.0554464
Snippet Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake...
Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake...
The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 603
SubjectTerms Adult
Biological and medical sciences
Compliance
Digestive system
Female
Gastric Fundus - drug effects
Gastric Fundus - physiology
Humans
Male
Medical sciences
Paroxetine - pharmacology
Perception
Pharmacology. Drug treatments
Pressure
Serotonin Uptake Inhibitors - pharmacology
Title Influence of the selective serotonin re‐uptake inhibitor, paroxetine, on gastric sensorimotor function in humans
URI https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2036.2003.01469.x
https://www.ncbi.nlm.nih.gov/pubmed/12622770
https://www.proquest.com/docview/73084844
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEB1KDqFQ-v3hNk116DFenLUsyceQNKSFlFISyM1I8rgNW-zF9kLJKT-hv7G_pDOynWVLDqH0ZliPsWZnRk_W6D2A99oa67BUsba0XJVJSSnlJMaJVU7lVelVkAM6_axOzuWni-xi7H_iszADP8TNBzfOjFCvOcGtG1RIksBuO3VoUQkOtJ4zpkHJZ4wn6Qem0T_6umaSUjq0H9KKI4_nZj8dm3rGDc5bH7QxUz1Y2o6cVg1qF7fB0U10G6an40ewmAY2dKUsZqvezfzVX5yP_2fkj-HhiGLFwRB2T-Ae1k9h-3Tcp38G7cdJ-0Q0lSCMKbqgt0Olla7apuePwKLF39e_VsveLlBc1t8vHVWXdk8sLQ2CT2Ljnmhq8c2ytIgnu7prWg6tphU8HXNIkZ0IMoPdczg__nB2eBKP6g6xlzlrMNDC0rkSmYEeM5Oq1BqnXWot2sqhzrRDwoZz53Xiq7yiG7PEOo8K5xRJOn0BW3VT4ysQhFO8oWDMK_KQN97Q80ziS6NkRUs2jEBP_2ThR-pzVuD4UYQteMnH1dilBbuUhTnTIri0-BnB_o3lcqD_uIPN7kawrA0lwz-ZRvBuip6Ckpl3aGyNzaorqNwaaaSM4OUQVGtb8sRc6yQCFULjzm9THHw546vX_2r4Bu6HBkYWwcl2YKtvV_iWgFjvdkOK_QGpaSZ1
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hVgIk1PJPKLQ-cGyWdOPYzrECqi10K4S2Um-W7ThQtUpWSVZCnHgEnpEnYcbJdrWohwpxy2EnWk9mxt94xvMBvJFGGesLEUuD6SpPCnQpy32cGGFFXhZOBDqg6amYnPGP59n5QAdEd2H6-RDXB27kGSFek4PTgfTboSzZe3lo0cIYHOZ6jmgOSj5CQLnJEXdQJvb-y2qWlJChARFzjjweq4N0aOsZSpw3vmltr3owNy2qrez5Lm4CpOv4NmxQR9twtVxa35dyOVp0duR-_DX18T-t_SFsDUCWHfaW9wju-Oox3J0Opfon0Bwv6U9YXTKEmawNlDsYXfGpqTs6B2aN__3z12LemUvPLqpvFxYDTLPP5gZXQZex_T6rK_bVELuIQ7mqrRuyrrphtCOTVaEcC0yD7VM4O_owezeJB4KH2PGcaBgwt7S28DSE3mcqFalRVtrUGG9K62UmrUd4OLZOJq7MS_xhlhjrvPBjNCaZPoONqq78C2AIVZxCe8xL1JBTTuH7VOIKJXiJWZuPQC4_pXbD9HMi4bjSoQrP6cYaqVSTSombM9VBpfp7BAfXkvN-AsgtZHbXrGUlyAkB8jSCvaX5aPRnKtKYyteLVmPEVVxxHsHz3qpWsqiJsZRJBCLYxq3_jT78PKOnl_8quAf3JrPpiT45Pv20A_dDPyNx4mSvYKNrFv414rLO7gZ_-wMVWSqU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hIlVIqPxD-Gl94Ngs6caxnWMFrFqgVYVaqbfIduxSLUqiJCtVnHgEnpEnYcbJdrWohwpx8yFjxZOZ8efMeD6At1IrbVwpYqnxuMqTEl3KcBcnWhiR-9KKQAd0dCwOzvin8-x8rH-iuzBDf4jrH27kGSFek4M3pX83ZiUHJw8VWhiCQ1vPCbVBySeIJ-9ygcCCANLXVSspIUP9IR458niq9tKxqmfMcN4409pWdb_RHWrND3QXN-HRdXgb9qfZA5gvVzaUpcwni95M7I-_mj7-n6U_hK0RxrL9we4ewR1XPYbNozFR_wTawyX5Cas9Q5DJukC4g7EVR23d019g1rrfP38tml7PHbusvl0aDC_tLms0LoKuYrtdVlfsQhO3iEW5qqtbsq26ZbQfk02hHAs8g91TOJt9PH1_EI_0DrHlOZEw4MnSmNJRC3qXqVSkWhlpUq2d9sbJTBqH4HBqrEyszz0-mCXaWCfcFE1Jps9go6or9wIYAhWr0BpzjxqyyiqcTyW2VIJ7PLO5COTySxZ27H1OFBzfi5CD53RfjVRakEqJmTMtgkqLqwj2riWbof_HLWS214xlJcgJ__E0gp2l9RTozZSi0ZWrF12B8VZxxXkEzwejWsmiJqZSJhGIYBq3fpti_-SURi__VXAHNk8-zIovh8efX8G9UMxIhDjZa9jo24V7g6CsN9vB2_4AaTEpQw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+the+selective+serotonin+re%E2%80%90uptake+inhibitor%2C+paroxetine%2C+on+gastric+sensorimotor+function+in+humans&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Tack%2C+J.&rft.au=Broekaert%2C+D.&rft.au=Coulie%2C+B.&rft.au=Fischler%2C+B.&rft.date=2003-02-15&rft.pub=Blackwell+Science+Ltd&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=17&rft.issue=4&rft.spage=603&rft.epage=608&rft_id=info:doi/10.1046%2Fj.1365-2036.2003.01469.x&rft.externalDBID=10.1046%252Fj.1365-2036.2003.01469.x&rft.externalDocID=APT1469
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon